Evidence map›Paper›PMID 23919682›Full record

ArticleClinical and experimental immunology2013

Complement alternative pathway genetic variation and Dengue infection in the Thai population.

R Kraivong, S Vasanawathana, W Limpitikul, P Malasit, N Tangthawornchaikul, M Botto, G R Screaton, J Mongkolsapaya, M C Pickering

Open access · hybridAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

R KraivongMolecular Immunology, Imperial College, London, UK.
S Vasanawathana
W Limpitikul
P Malasit
N Tangthawornchaikul
M Botto
G R Screaton
J Mongkolsapaya
M C Pickering
Imperial College London · GBMinistry of Public Health · THCentre for Inflammation Research · GBMahidol University · THNational Science and Technology Development Agency · THSiriraj Hospital · TH

Funding

Medical Research Council G0400720Medical Research Council G0801508Wellcome Trust 095541
6 · The paper itself

Abstract

Dengue disease is a mosquito-borne infection caused by Dengue virus. Infection may be asymptomatic or variably manifest as mild Dengue fever (DF) to the most severe form, Dengue haemorrhagic fever (DHF). Mechanisms that influence disease severity are not understood. Complement, an integral component of the immune system, is activated during Dengue infection and the degree of activation increases with disease severity. Activation of the complement alternative pathway is influenced by polymorphisms within activation (factor B rs12614/rs641153, C3 rs2230199) and regulatory [complement factor H (CFH) rs800292] proteins, collectively termed a complotype. Here, we tested the hypothesis that the complotype influences disease severity during secondary Dengue infection. In addition to the complotype, we also assessed two other disease-associated CFH polymorphisms (rs1061170, rs3753394) and a structural polymorphism within the CFH protein family. We did not detect any significant association between the examined polymorphisms and Dengue infection severity in the Thai population. However, the minor allele frequencies of the factor B and C3 polymorphisms were less than 10%, so our study was not sufficiently powered to detect an association at these loci. We were also unable to detect a direct interaction between CFH and Dengue NS1 using both recombinant NS1 and DV2-infected culture supernatants. We conclude that the complotype does not influence secondary Dengue infection severity in the Thai population.

Indexed as

Dengue VirusAdolescentAdultCells, CulturedChildChild, PreschoolComplement C3Complement Factor BComplement Factor HComplement Pathway, AlternativeDengueFemaleGenetic Association StudiesGenetic Predisposition to DiseaseHumansMaleComplement C3Complement Factor BComplement Factor Halternative complement pathwayDengue infectiongenetic polymorphism

Identifiers

PMID23919682
PMCPMC3828836
OpenAlexW1568587228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.